Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form SC 13G AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Form SC 13D/A Celator Pharmaceuticals Filed by: CAXTON CORP
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Manhattan Institute Announces Recipients of the Sixteenth Annual Alexander Hamilton Award
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G/A PLY GEM HOLDINGS INC Filed by: Caxton-Iseman (Ply Gem), L.P.
-
MGM Resorts International Announces Board of Directors for MGM Growth Properties
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Caxton Corp cuts stake in Market Vectors Gold Miner ETF third quarter: filing
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Synta Reports Third Quarter 2015 Financial Results
-
Ash Farr Promoted to McCann Worldgroup Global Role As EVP, Global Director of Strategy and Research, Commonwealth//McCann
-
Chiron Investment Management Expands Senior Executive Team
-
Caxton is said to be up 3.5% month-to-date - WSJ
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Mevion Medical Systems Forming Joint Venture in China and Secures up to $200MM in Financing
-
Caxton Alternative Management Announces Name Change to CAM Capital
-
Quad Group Expands Futures Trading Desk with Key Hires
-
AB's Second Real Estate Private Equity Fund Surpasses $1.2 Billion In Commitments
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Caledonia Mining Corporation: Chairman's Statement at the Forthcoming Annual General Meeting
-
Applied Minerals Appoints Bradley Tirpak to Board of Directors
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A PLY GEM HOLDINGS INC Filed by: Caxton-Iseman (Ply Gem), L.P.
-
Agile Therapeutics (AGRX) Announces $20M Private Placement; Updates Phase 3 SECURE Study
-
Form SC 13D/A Celator Pharmaceuticals Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form SC 13D/A OVERSEAS SHIPHOLDING Filed by: CAXTON INTERNATIONAL LTD
-
Form SC 13D/A OVERSEAS SHIPHOLDING Filed by: CAXTON ASSOCIATES LP
-
Synta Pharma (SNTA) Enters 1.25M Common Sales Agreement at $4.01/Share
-
Annaly Capital Management (NLY) Makes Several Management Promotions, Additions
-
Synta Pharmaceuticals (SNTA) CEO Continues to Load Up
-
Synta Pharmaceuticals (SNTA) CEO Buys Another 10K Shares
-
Synta Pharmaceuticals (SNTA) CEO Steps Up with Buy Post 70% Collapse
-
Caxton Associates Raises Stake in US Airways Group, Inc. (LCC) to 5.39%
-
Big Hedge Funds are Moving Cash into Housing... Really??
-
Caxton Global Announces Departure of Two Co-Founders, Kovner & D’Angelo
-
Caxton Investment's Chairman, CEO Kovner, Pres D'Angelo to retire; Andrew Law named as successor to Kovner
-
Synta Pharma (SNTA) Completes 1.44M Common Sale to Board Member

